Menactra®
Menactra® is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. It is approved for use in individuals 9 months through 55 years of age.
1:03:40
Vaccinate against meningococcal meningitis
00:01:06
Menactra: Preventing meningococcal meningitis in India
The relevant and trusted MCV in India to fight against meningococcal meningitis
00:03:00
10 years and still going strong with Menactra
00:00:30
Why didn’t we know about this vaccine?
00:02:00
IMD progression & consequences are inversely proportional to age
0:04:55
IMD Roadshow: Defeating meningitis by 2023: Dr. Jaydeep Choudhury
00:00:30
The startling statistics of IMD severity
Disclaimer: The images depicted here are fictitious and meant for illustrative purpose only. Any resemblance to any person, living or dead is purely coincidental.